UnitedHealth Group (UNH) has been on my watchlist.  It’s faced several obstacles this year: DOJ antitrust investigation; significant data breach; Biden and now Trump regulatory intervention; and this week the assassination of its CEO.

Through all the obstacles, UNH remains a financial powerhouse and is favored by long term trends of an aging population and technological advancements in healthcare.  While many uncertainties exist, I used this current setback to establish a position in the company.

UNH is a portfolio accumulation type stock, where it’s bought on the dip and then forgotten about.

If you find these ALERTs informative, please share them with a likeminded friend AND reference this post on your website or social media channels.

—————————————————–